Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ECS elaborated

G P Rodnan

    The New England Journal of Medicine
    |January 27, 1972
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities.

    Annals of internal medicine·1986
    Same author

    Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis.

    Arthritis and rheumatism·1986
    Same author

    Persistence of scleroderma-like phenotype in normal fibroblasts after prolonged exposure to soluble mediators from mononuclear cells.

    Arthritis and rheumatism·1986
    Same author

    The effect of D-penicillamine on pulmonary findings in systemic sclerosis.

    Arthritis and rheumatism·1985
    Same author

    Pulmonary involvement in systemic sclerosis (scleroderma).

    Arthritis and rheumatism·1985
    Same author

    Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients.

    Arthritis and rheumatism·1985
    Same journal

    Advances in Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

    The New England journal of medicine·2026
    Same journal

    Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

    The New England journal of medicine·2026
    See all related articles